{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:15:15Z","timestamp":1753892115366,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Friedreich ataxia (FRDA) is a progressive neurodegenerative disorder with specific clinical manifestations, such as scoliosis, which may impact the management of cardiac arrhythmias and heart failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>A 17-year-old male with FRDA and hypertrophic cardiomyopathy presented with atrial flutter and resultant acute-on-chronic systolic and diastolic heart failure with reduced ejection fraction. The arrhythmias were refractory to medical management with adenosine and amiodarone. An attempted cavotricuspid isthmus ablation was unsuccessful due to abnormal cardiac positioning caused by severe scoliosis. Despite optimization with dofetilide and metoprolol, he was readmitted with recurrent atrial arrhythmias and cardiogenic shock, secondary to probable amiodarone-induced thyrotoxicosis, requiring extracorporeal membrane oxygenation. His clinical course involved multisystem complications, prolonged hospitalization, and disease progression, with no recovery in systolic function despite control of his arrhythmia burden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Intensivists should be cognizant of multisystem complications that can arise when treating refractory cardiac arrhythmias, especially in those with concomitant genetic conditions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1542513","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:24:21Z","timestamp":1745904261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Complex cardiac arrhythmia management in the ICU for an adolescent with Friedreich ataxia"],"prefix":"10.3389","volume":"13","author":[{"given":"Oluwatomini A.","family":"Fashina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Gleich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek N.","family":"Opp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Ouellette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13023-014-0184-7","article-title":"Consensus clinical management guidelines for Friedreich ataxia","volume":"9","author":"Corben","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich ataxia: pathology, pathogenesis, and molecular genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"J Neurol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia","volume":"335","author":"Durr","year":"1996","journal-title":"N Engl J Med"},{"key":"B4","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla","year":"1996","journal-title":"Am J Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1499","DOI":"10.1212\/WNL.0000000000200913","article-title":"Natural history of Friedreich ataxia: heterogeneity of neurologic progression and consequences for clinical trial design","volume":"99","author":"Rummey","year":"2022","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/acn3.51352","article-title":"Scoliosis in Friedreich\u2019s ataxia: longitudinal characterization in a large heterogeneous cohort","volume":"8","author":"Rummey","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13023-020-01475-9","article-title":"Onset features and time to diagnosis in Friedreich\u2019s ataxia","volume":"15","author":"Indelicato","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich\u2019s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e917","DOI":"10.1212\/WNL.0000000000006121","article-title":"Nonataxia symptoms in Friedreich ataxia: report from the registry of the European Friedreich\u2019s Ataxia Consortium for Translational Studies (EFACTS)","volume":"91","author":"Reetz","year":"2018","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.amjcard.2011.09.025","article-title":"Analysis of echocardiograms in a large heterogeneous cohort of patients with Friedreich ataxia","volume":"109","author":"Regner","year":"2012","journal-title":"Am J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J Neurol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.111.059477","article-title":"The heart in Friedreich ataxia","volume":"125","author":"Weidemann","year":"2012","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40265-023-01874-9","article-title":"Omaveloxolone: first approval","volume":"83","author":"Lee","year":"2023","journal-title":"Drugs"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/oxfordjournals.eurheartj.a060072","article-title":"Cardiomyopathy in Friedreich\u2019s ataxia: a doppler-echocardiographic study","volume":"13","author":"Morvan","year":"1992","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4330\/wjc.v11.i1.1","article-title":"Heart disease in Friedreich\u2019s ataxia","volume":"11","author":"Hanson","year":"2019","journal-title":"World J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.redare.2023.06.002","article-title":"Anaesthestic management of thyroid storm in a patient with Friedreich\u2019s ataxia. A case report","volume":"70","author":"Sneyers Closa","year":"2023","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"B17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/MOP.0b013e32833a4511","article-title":"Graves\u2019 disease in a patient with Friedreich\u2019s ataxia and diabetes mellitus","volume":"22","author":"Schweiger","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1177\/0883073811435242","article-title":"Cardiac dysfunction exacerbated by endocrinopathies in Friedreich ataxia: a case series","volume":"27","author":"Snyder","year":"2012","journal-title":"J Child Neurol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1542513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:24:22Z","timestamp":1745904262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1542513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":18,"alternative-id":["10.3389\/fped.2025.1542513"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1542513","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"article-number":"1542513"}}